INNATE PHARMA SA-SPONS ADR
IPHANASDAQ🏆 #3777 by market capEarnings Nov 5 · PreUS Equity
$1.50▼ $0.02 (−1.32%)
🌙 After hours$1.50▲ 0.00%Regular close · extended-hours price shownTrack IPHA
Get earnings, price moves & breaking news on Telegram
24h▼ 1.3%
7d▲ 0.0%
14d▼ 1.3%
30d▼ 9.4%
ytd▼ 15.7%
1y▼ 25.0%
🏦Market Cap
$151M
Small Cap
📈Revenue Growth (YoY)
-77.9%
Declining
📊Gross Margin
1770.3%
High
💵FCF Margin
-4108.2%
Thin
⚖️P/S Ratio
115.9x
Expensive
Otter Score
—
Insufficient data
INNATE PHARMA SA-SPONS ADR
IPHAAnalyst Ratings
Price
$1.50
Total
6
Raised
0
Lowered
1
Avg PT
$6.67
H / L
$9 / $4
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
BTIG | Reiterated | Buy | 2026-09-17 | $9.00 | +500.00% |
HC Wainwright & Co. | Reiterated | Buy | 2026-08-10 | — | — |
Leerink Partners | Downgraded | Outperform → Market Perform | 2025-09-18 | $4.00 | +166.70% |
SVB Leerink | Reiterated | Outperform | 2022-11-15 | — | — |
Citigroup | Reiterated | Buy | 2022-09-16 | — | — |
Goldman Sachs | Reiterated | Neutral | 2020-11-24 | — | — |
Institution
BTIG
Reiterated · Buy · 2026-09-17
$9.00
+500.00%
HC Wainwright & Co.
Reiterated · Buy · 2026-08-10
—
—
Leerink Partners
Downgraded · Outperform → Market Perform · 2025-09-18
$4.00
+166.70%
SVB Leerink
Reiterated · Outperform · 2022-11-15
—
—
Citigroup
Reiterated · Buy · 2022-09-16
—
—
Goldman Sachs
Reiterated · Neutral · 2020-11-24
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space